Targeted therapies [electronic resource] : mechanisms of resistance / Daniel Gioeli, editor.
This volume explores the mechanisms of resistance to targeted therapeutics.¡The focus is on the cancer cell signaling network, ¡although other mechanisms of resistance including target¡mutation, and new areas of study such as cancer stem cells are included.¡ Targeted Therapies: Mechanisms of Resista...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York :
Humana Press,
©2011.
|
| Series: | Molecular and translational medicine.
|
| Subjects: |
MARC
| LEADER | 00000cam a2200000xa 4500 | ||
|---|---|---|---|
| 001 | b6699452 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 110804s2011 nyua ob 001 0 eng d | ||
| 005 | 20240423170939.9 | ||
| 019 | |a 742513780 |a 985046352 |a 1005794197 |a 1111026587 |a 1204072220 | ||
| 020 | |a 9781607614784 |q (electronic bk.) | ||
| 020 | |a 1607614782 |q (electronic bk.) | ||
| 020 | |a 1607614774 | ||
| 020 | |a 9781607614777 | ||
| 020 | |z 9781607614777 | ||
| 024 | 7 | |a 10.1007/978-1-60761-478-4 | |
| 035 | |a (OCoLC)spr745005722 | ||
| 035 | |a (OCoLC)745005722 |z (OCoLC)742513780 |z (OCoLC)985046352 |z (OCoLC)1005794197 |z (OCoLC)1111026587 |z (OCoLC)1204072220 | ||
| 037 | |a spr978-1-60761-478-4 | ||
| 040 | |a GW5XE |b eng |e pn |c GW5XE |d OCLCQ |d VAM |d COO |d OCLCQ |d VZR |d OCLCF |d BEDGE |d E7B |d EBLCP |d YDXCP |d OCLCQ |d TXI |d OCLCQ |d VT2 |d OCLCO |d ESU |d IOG |d OCLCO |d OCLCA |d BUF |d OCLCO |d CEF |d U3W |d AU@ |d OCLCQ |d WYU |d UWO |d YOU |d OCLCQ |d LEAUB |d CNTRU |d OCLCO |d UKAHL |d OCLCQ |d OCLCA |d AJS |d DCT |d OCLCQ |d OCLCO | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a RM301.63 |b .T37 2011 | |
| 245 | 0 | 0 | |a Targeted therapies |h [electronic resource] : |b mechanisms of resistance / |c Daniel Gioeli, editor. |
| 260 | |a New York : |b Humana Press, |c ©2011. | ||
| 300 | |a 1 online resource (xiv, 201 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 347 | |a text file. | ||
| 347 | |b PDF. | ||
| 490 | 1 | |a Molecular and translational medicine. | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Resistance to Targeted Therapies As a Result of Mutation(s) in the Target -- The Dynamics of the Cell Signaling Network; Implications for Targeted Therapies -- Cancer Signaling Network Analysis by Quantitative Mass Spectrometry -- Development and Implementation of Array Technologies for Proteomics: Clinical Implications and Applications -- Using Phosphoflow[tm] to Study Signaling Events of Subpopulations Resistant to Current Therapies -- Mathematical and Computational Models in Cancer -- Somatic Evolution of Acquired Drug Resistance in Cancer -- Interrogating Resistance to Targeted Therapy Using Genetically Engineered Mouse Models of Cancer -- microRNA: A Potential Therapy Able to Target Multiple Cancer Pathways -- Rational Combination of Targeted Agents to Overcome Cancer Cell Resistance. | |
| 520 | |a This volume explores the mechanisms of resistance to targeted therapeutics.¡The focus is on the cancer cell signaling network, ¡although other mechanisms of resistance including target¡mutation, and new areas of study such as cancer stem cells are included.¡ Targeted Therapies: Mechanisms of Resistance highlights examples of changes in the signaling network in response to inhibition of a signaling event and underscores the importance in having a mechanistic understanding of the signaling network in cancer for developing effective targeted cancer therapies. Moreover, cutting edge tools to analyze the cell signaling network will be discussed. This includes the leading edge of techniques as well as computational biology and systems theory. This volume provides the reader with both an overview as well as a detailed perspective on the mechanisms of resistance to targeted therapeutics and will be of great value to the oncologist, the physician-scientist treating patients and the translational scientist working on any aspect of targeted therapeutics. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Drug targeting. |0 http://id.loc.gov/authorities/subjects/sh88005350. | |
| 650 | 7 | |a Drug targeting. |2 fast |0 (OCoLC)fst00898709. | |
| 700 | 1 | |a Gioeli, Daniel. |0 http://id.loc.gov/authorities/names/n2011183815 |1 http://isni.org/isni/0000000140194389. | |
| 776 | 0 | 8 | |i Print version: |t Targeted therapies. |d New York : Humana Press, 2011 |w (DLC) 2011928683. |
| 830 | 0 | |a Molecular and translational medicine. |0 http://id.loc.gov/authorities/names/no2010202135. | |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-1-60761-478-4 |z Full Text (via Springer) |
| 907 | |a .b66994524 |b 04-01-21 |c 08-16-11 | ||
| 998 | |a web |b 03-31-21 |c b |d b |e - |f eng |g nyu |h 0 |i 1 | ||
| 907 | |a .b66994524 |b 03-31-21 |c 08-16-11 | ||
| 944 | |a MARS - RDA ENRICHED | ||
| 956 | |b Springer Nature - Springer Medicine eBooks 2011 English International | ||
| 915 | |a - | ||
| 956 | |a Springer e-books | ||
| 956 | |b Springer Nature - Springer Medicine eBooks 2011 English International | ||
| 999 | f | f | |i c0860395-6ba9-5bff-ba75-07129959060f |s f570dfc3-af9b-54a4-98ca-899bdb958cb6 |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RM301.63 .T37 2011 |h Library of Congress classification |i Ebooks, Prospector |n 1 |